Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? A UK perspective on technique and quality assurance.

Journal article

Aims

The treatment of prostate cancer has evolved markedly over the last 40 years, including radiotherapy, notably with escalated dose and targeting. However, the optimal treatment for localised disease has not been established in comparative randomised trials. The aim of this article is to describe the history of prostate radiotherapy trials, including their quality assurance processes, and to compare these with the ProtecT trial.

Materials and methods

The UK Pro...

Expand abstract

Authors: Mason, MD; Moore, R; Jones, G; Lewis, G; Donovan, JL

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Elsevier Publisher's website
• Journal: Clinical Oncology Journal website
• Volume: 28
• Issue: 9
• Pages: e92-e100
• Publication date: 2016-07-12
• Acceptance date: 2016-05-16
• DOI: 10.1016/j.clon.2016.05.011
• EISSN: 1433-2981
• ISSN: 0936-6555
• Pmid: 27425582
• Language: English
• Keywords: Surveys and Questionnaires; Male; Quality Assurance, Health Care; Humans; quality assurance; Radiation Oncology; radiotherapy; Retrospective Studies; Prostatic Neoplasms; Radiotherapy, Conformal; ProtecT Study Group; Prostate cancer; Clinical Trials as Topic; randomised controlled trials